Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Canetta

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
Intraperitoneal carboplatin: favorable results in women with minimal residual ovarian cancer after cisplatin therapyJ L Speyer, U Beller, N Colombo, et al.
Blood|December 15, 1992
Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus diseaseL P Schacter, M Rozencweig, M Beltangady, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trialJ S Abrams, D A Vena, J Baltz, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
Clinical development of TaxolS G Arbuck, M C Christian, J S Fisherman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103E L Trimble, J D Adams, D Vena, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancerJ F Bishop, J Dewar, G C Toner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Long-term results and pharmacokinetics of high-dose paclitaxel in patients with refractory epithelial ovarian carcinomaA. P. Kudelka, C. F. Verschraegen, Y. Shen, et al.
British Journal of Cancer|December 4, 1998
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' GroupK Aabo, M Adams, P Adnitt, et al.
Cancer Treatment Reports|May 1, 1979
Adriamycin cardiotoxicity: a survey of 1273 patientsC Praga, G Beretta, P L Vigo, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
Intraperitoneal carboplatin: favorable results in women with minimal residual ovarian cancer after cisplatin therapyJ L Speyer, U Beller, N Colombo, et al.
Blood|December 15, 1992
Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus diseaseL P Schacter, M Rozencweig, M Beltangady, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trialJ S Abrams, D A Vena, J Baltz, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
Clinical development of TaxolS G Arbuck, M C Christian, J S Fisherman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103E L Trimble, J D Adams, D Vena, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancerJ F Bishop, J Dewar, G C Toner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Long-term results and pharmacokinetics of high-dose paclitaxel in patients with refractory epithelial ovarian carcinomaA. P. Kudelka, C. F. Verschraegen, Y. Shen, et al.
British Journal of Cancer|December 4, 1998
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' GroupK Aabo, M Adams, P Adnitt, et al.
Cancer Treatment Reports|May 1, 1979
Adriamycin cardiotoxicity: a survey of 1273 patientsC Praga, G Beretta, P L Vigo, et al.
Pageof 4